Friday, April 24, 2026
33 C
Bengaluru

What about Indian Pharma?

MedicinMan June 2015

[wpfilebase tag=file id=48 tpl=download-button /]

Inside this Issue

1. Seven Sutras to Kick Start Your Product Management Career by Soham Wagh

Small steps to make the big leap from field sales to product management.

2.  Four Questions Every Learning & Development Professional Should Ask by Dr Rajshri Jobanputra

Adopting Chan Kim and Renée Mauborgne’s ERRC framework (Eliminate, Reduce, Raise and Create) to create real value for learners.

3.  Brilliant Basics by K. Hariram

Revisiting the basics of sales success.

4.  Brand Building: Beneath the Iceberg by Vivek Hattangadi

The real power of a brand comes from the intangible values associated with it such as warmth, concern, and sentimentality.

5.  Delivery Boy to Company President by Rashesh Patel

The Success Story of Rashesh Patel – President, Corona Remedies

6.  The Abilene Paradox by Vivek Hattangadi

The Inability to Manage Agreement

Hot this week

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Will the GLP Battle Now Shift from Injectable to Oral?

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article